Cargando…

Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria

BACKGROUND: Traditional antibiotics are increasingly suffering from the emergence of multidrug resistance amongst pathogenic bacteria leading to a range of novel approaches to control microbial infections being investigated as potential alternative treatments. One plausible antimicrobial alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiamegos, Yiannis C., Kastritis, Panagiotis L., Exarchou, Vassiliki, Han, Haley, Bonvin, Alexandre M. J. J., Vervoort, Jacques, Lewis, Kim, Hamblin, Michael R., Tegos, George P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070693/
https://www.ncbi.nlm.nih.gov/pubmed/21483731
http://dx.doi.org/10.1371/journal.pone.0018127
_version_ 1782201409271234560
author Fiamegos, Yiannis C.
Kastritis, Panagiotis L.
Exarchou, Vassiliki
Han, Haley
Bonvin, Alexandre M. J. J.
Vervoort, Jacques
Lewis, Kim
Hamblin, Michael R.
Tegos, George P.
author_facet Fiamegos, Yiannis C.
Kastritis, Panagiotis L.
Exarchou, Vassiliki
Han, Haley
Bonvin, Alexandre M. J. J.
Vervoort, Jacques
Lewis, Kim
Hamblin, Michael R.
Tegos, George P.
author_sort Fiamegos, Yiannis C.
collection PubMed
description BACKGROUND: Traditional antibiotics are increasingly suffering from the emergence of multidrug resistance amongst pathogenic bacteria leading to a range of novel approaches to control microbial infections being investigated as potential alternative treatments. One plausible antimicrobial alternative could be the combination of conventional antimicrobial agents/antibiotics with small molecules which block multidrug efflux systems known as efflux pump inhibitors. Bioassay-driven purification and structural determination of compounds from plant sources have yielded a number of pump inhibitors which acted against gram positive bacteria. METHODOLOGY/PRINCIPAL FINDINGS: In this study we report the identification and characterization of 4′,5′-O-dicaffeoylquinic acid (4′,5′-ODCQA) from Artemisia absinthium as a pump inhibitor with a potential of targeting efflux systems in a wide panel of Gram-positive human pathogenic bacteria. Separation and identification of phenolic compounds (chlorogenic acid, 3′,5′-ODCQA, 4′,5′-ODCQA) was based on hyphenated chromatographic techniques such as liquid chromatography with post column solid-phase extraction coupled with nuclear magnetic resonance spectroscopy and mass spectroscopy. Microbial susceptibility testing and potentiation of well know pump substrates revealed at least two active compounds; chlorogenic acid with weak antimicrobial activity and 4′,5′-ODCQA with pump inhibitory activity whereas 3′,5′-ODCQA was ineffective. These intitial findings were further validated with checkerboard, berberine accumulation efflux assays using efflux-related phenotypes and clinical isolates as well as molecular modeling methodology. CONCLUSIONS/SIGNIFICANCE: These techniques facilitated the direct analysis of the active components from plant extracts, as well as dramatically reduced the time needed to analyze the compounds, without the need for prior isolation. The calculated energetics of the docking poses supported the biological information for the inhibitory capabilities of 4′,5′-ODCQA and furthermore contributed evidence that CQAs show a preferential binding to Major Facilitator Super family efflux systems, a key multidrug resistance determinant in gram-positive bacteria.
format Text
id pubmed-3070693
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30706932011-04-11 Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria Fiamegos, Yiannis C. Kastritis, Panagiotis L. Exarchou, Vassiliki Han, Haley Bonvin, Alexandre M. J. J. Vervoort, Jacques Lewis, Kim Hamblin, Michael R. Tegos, George P. PLoS One Research Article BACKGROUND: Traditional antibiotics are increasingly suffering from the emergence of multidrug resistance amongst pathogenic bacteria leading to a range of novel approaches to control microbial infections being investigated as potential alternative treatments. One plausible antimicrobial alternative could be the combination of conventional antimicrobial agents/antibiotics with small molecules which block multidrug efflux systems known as efflux pump inhibitors. Bioassay-driven purification and structural determination of compounds from plant sources have yielded a number of pump inhibitors which acted against gram positive bacteria. METHODOLOGY/PRINCIPAL FINDINGS: In this study we report the identification and characterization of 4′,5′-O-dicaffeoylquinic acid (4′,5′-ODCQA) from Artemisia absinthium as a pump inhibitor with a potential of targeting efflux systems in a wide panel of Gram-positive human pathogenic bacteria. Separation and identification of phenolic compounds (chlorogenic acid, 3′,5′-ODCQA, 4′,5′-ODCQA) was based on hyphenated chromatographic techniques such as liquid chromatography with post column solid-phase extraction coupled with nuclear magnetic resonance spectroscopy and mass spectroscopy. Microbial susceptibility testing and potentiation of well know pump substrates revealed at least two active compounds; chlorogenic acid with weak antimicrobial activity and 4′,5′-ODCQA with pump inhibitory activity whereas 3′,5′-ODCQA was ineffective. These intitial findings were further validated with checkerboard, berberine accumulation efflux assays using efflux-related phenotypes and clinical isolates as well as molecular modeling methodology. CONCLUSIONS/SIGNIFICANCE: These techniques facilitated the direct analysis of the active components from plant extracts, as well as dramatically reduced the time needed to analyze the compounds, without the need for prior isolation. The calculated energetics of the docking poses supported the biological information for the inhibitory capabilities of 4′,5′-ODCQA and furthermore contributed evidence that CQAs show a preferential binding to Major Facilitator Super family efflux systems, a key multidrug resistance determinant in gram-positive bacteria. Public Library of Science 2011-04-04 /pmc/articles/PMC3070693/ /pubmed/21483731 http://dx.doi.org/10.1371/journal.pone.0018127 Text en Fiamegos et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fiamegos, Yiannis C.
Kastritis, Panagiotis L.
Exarchou, Vassiliki
Han, Haley
Bonvin, Alexandre M. J. J.
Vervoort, Jacques
Lewis, Kim
Hamblin, Michael R.
Tegos, George P.
Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
title Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
title_full Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
title_fullStr Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
title_full_unstemmed Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
title_short Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
title_sort antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from artemisia absinthium against gram-positive pathogenic bacteria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070693/
https://www.ncbi.nlm.nih.gov/pubmed/21483731
http://dx.doi.org/10.1371/journal.pone.0018127
work_keys_str_mv AT fiamegosyiannisc antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT kastritispanagiotisl antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT exarchouvassiliki antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT hanhaley antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT bonvinalexandremjj antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT vervoortjacques antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT lewiskim antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT hamblinmichaelr antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria
AT tegosgeorgep antimicrobialandeffluxpumpinhibitoryactivityofcaffeoylquinicacidsfromartemisiaabsinthiumagainstgrampositivepathogenicbacteria